| Primary |
| Cerebral Infarction |
22.6% |
| Antiplatelet Therapy |
17.2% |
| Intermittent Claudication |
16.0% |
| Arteriosclerosis Obliterans |
4.8% |
| Peripheral Arterial Occlusive Disease |
4.6% |
| Lacunar Infarction |
4.2% |
| Coronary Artery Disease |
4.0% |
| Diabetic Nephropathy |
2.8% |
| Peripheral Vascular Disorder |
2.6% |
| Angina Pectoris |
2.2% |
| Product Used For Unknown Indication |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Angiopathy |
2.0% |
| Arterial Occlusive Disease |
2.0% |
| Carotid Artery Stenosis |
2.0% |
| Thrombosis In Device |
2.0% |
| Hypertension |
1.8% |
| Cardiovascular Event Prophylaxis |
1.6% |
| Arteriosclerosis |
1.4% |
| Cerebral Artery Stenosis |
1.4% |
|
| Tachycardia |
11.2% |
| Thrombosis In Device |
9.7% |
| Ventricular Tachycardia |
6.0% |
| Vomiting |
6.0% |
| Pneumonia |
5.2% |
| Rhabdomyolysis |
5.2% |
| Shock |
5.2% |
| White Blood Cell Count Decreased |
5.2% |
| Coronary Revascularisation |
4.5% |
| Gastric Ulcer Haemorrhage |
4.5% |
| Haemorrhage Intracranial |
4.5% |
| Sinus Tachycardia |
4.5% |
| Gastrointestinal Haemorrhage |
3.7% |
| Lacunar Infarction |
3.7% |
| Palpitations |
3.7% |
| Renal Failure Acute |
3.7% |
| Ventricular Fibrillation |
3.7% |
| Weight Increased |
3.7% |
| Cardiac Disorder |
3.0% |
| Cardiac Failure |
3.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
23.2% |
| Product Used For Unknown Indication |
16.8% |
| Hypertension |
8.0% |
| Antiplatelet Therapy |
6.2% |
| Ventricular Tachycardia |
5.5% |
| Cerebral Infarction |
5.3% |
| Chronic Obstructive Pulmonary Disease |
4.8% |
| Rheumatoid Arthritis |
4.6% |
| Anticoagulant Therapy |
3.4% |
| Cerebral Thrombosis |
3.2% |
| Myocardial Infarction |
3.2% |
| Angina Pectoris |
2.5% |
| Cardiovascular Disorder |
2.1% |
| Thrombosis Prophylaxis |
2.1% |
| Atrial Fibrillation |
1.6% |
| Peripheral Arterial Occlusive Disease |
1.6% |
| Prophylaxis |
1.6% |
| Acute Myocardial Infarction |
1.4% |
| Cerebrovascular Spasm |
1.4% |
| Insomnia |
1.4% |
|
| Liver Disorder |
12.0% |
| Myocardial Infarction |
6.7% |
| Aortic Aneurysm Rupture |
5.3% |
| Implant Site Effusion |
5.3% |
| Shock |
5.3% |
| Suicide Attempt |
5.3% |
| Tachycardia |
5.3% |
| Thrombosis In Device |
5.3% |
| Upper Gastrointestinal Haemorrhage |
5.3% |
| Ventricular Extrasystoles |
5.3% |
| Ventricular Tachycardia |
5.3% |
| Cardiac Failure |
4.0% |
| Gastrointestinal Haemorrhage |
4.0% |
| Interstitial Lung Disease |
4.0% |
| Renal Impairment |
4.0% |
| Subdural Haematoma |
4.0% |
| Treatment Noncompliance |
4.0% |
| Vomiting |
4.0% |
| Brain Stem Haemorrhage |
2.7% |
| Enterobacter Test Positive |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.4% |
| Drug Use For Unknown Indication |
14.9% |
| Hypertension |
14.6% |
| Diabetes Mellitus |
5.2% |
| Type 2 Diabetes Mellitus |
4.6% |
| Rheumatoid Arthritis |
4.2% |
| Prophylaxis |
3.1% |
| Pain |
2.7% |
| Blood Cholesterol Increased |
2.4% |
| Nuclear Magnetic Resonance Imaging |
2.1% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Blood Pressure |
1.9% |
| Cardiac Disorder |
1.8% |
| Insomnia |
1.6% |
| Cardiovascular Disorder |
1.6% |
| Constipation |
1.6% |
| Atrial Fibrillation |
1.5% |
| Non-small Cell Lung Cancer |
1.4% |
| Bone Disorder |
1.4% |
| Anticoagulant Therapy |
1.3% |
|
| Vomiting |
11.0% |
| Weight Decreased |
8.0% |
| Rhabdomyolysis |
6.8% |
| Somnolence |
5.9% |
| Death |
5.5% |
| Drug Ineffective |
5.1% |
| Pruritus |
5.1% |
| Renal Impairment |
5.1% |
| Dyspnoea |
4.6% |
| Myocardial Infarction |
4.6% |
| Renal Failure |
4.6% |
| Diarrhoea |
4.2% |
| Pain In Extremity |
4.2% |
| Hyperglycaemia |
3.8% |
| Pneumonia |
3.8% |
| Unresponsive To Stimuli |
3.8% |
| Urinary Tract Infection |
3.8% |
| Blood Glucose Increased |
3.4% |
| Cardiac Failure Congestive |
3.4% |
| Cerebrovascular Accident |
3.4% |
|
| Interacting |
| Product Used For Unknown Indication |
18.6% |
| Restless Legs Syndrome |
17.1% |
| Resting Tremor |
8.6% |
| Skin Lesion |
7.1% |
| Cardiac Failure Congestive |
5.7% |
| Drug Use For Unknown Indication |
4.3% |
| Fungal Skin Infection |
4.3% |
| Pruritus Genital |
4.3% |
| Arteriosclerosis |
2.9% |
| Cardiac Disorder |
2.9% |
| Depression |
2.9% |
| Diabetes Mellitus |
2.9% |
| Hypertension |
2.9% |
| Pain |
2.9% |
| Stent Placement |
2.9% |
| Tremor |
2.9% |
| Venous Insufficiency |
2.9% |
| Antiplatelet Therapy |
1.4% |
| Cardiovascular Disorder |
1.4% |
| Dyspnoea |
1.4% |
|
| Acinetobacter Test Positive |
10.3% |
| Pyrexia |
10.3% |
| Tremor |
10.3% |
| Atrioventricular Block First Degree |
6.9% |
| Somnolence |
6.9% |
| Urticaria Vesiculosa |
6.9% |
| Drug Interaction |
3.4% |
| Enterobacter Test Positive |
3.4% |
| Epidermolysis |
3.4% |
| Headache |
3.4% |
| Hypotension |
3.4% |
| Leukopenia |
3.4% |
| Nikolsky's Sign |
3.4% |
| Overdose |
3.4% |
| Pruritus |
3.4% |
| Pseudobulbar Palsy |
3.4% |
| Skin Exfoliation |
3.4% |
| Staphylococcus Test Positive |
3.4% |
| Stevens-johnson Syndrome |
3.4% |
| Urticaria |
3.4% |
|
